NEUVIOR
NEUVIOR®
Why we exist

Our Mission

Science, access and ethics in one operating model.

NEUVIOR exists to restore confidence in medicine by building infrastructure that makes medicines systems more intelligent, more resilient and more accountable.

Our Purpose

Why we exist

Medicines systems are under pressure from cost inflation, fragmentation, supply disruption and declining trust. NEUVIOR was created to build the infrastructure layer that helps health systems act with more clarity and more confidence.

We believe better medicines value, stronger governance and better deployment discipline can coexist. The aim is not more noise. It is better decisions, faster execution and safer outcomes.

Our purpose is to make medicine systems more trusted, more efficient and more resilient.

Mission pillars

Our three pillars

Every product decision, operating choice and external claim should strengthen one or more of these pillars without compromising the others.

Innovation — pharmaceutical lab
Innovation
Infrastructure-led innovation

Innovation

Build products and operating models that move from insight to action in regulated environments.

Our Commitments

  • Develop PHARMORIS® around Discover / Justify / Deploy
  • Protect differentiated architecture and workflows through IP
  • Build tools that solve real medicines value and supply problems
  • Extend from software into broader pharmaceutical infrastructure over time
Access — healthcare delivery
Access
Operational access

Access

Expand access to better-value medicines and more reliable supply across health systems and patient settings.

Our Commitments

  • Reduce medicines leakage and unwarranted variation
  • Support best-value generics and off-patent optimisation
  • Improve supply resilience and shortage response
  • Connect strategy with real-world provider and pharmacy deployment
Ethics — trusted practitioner
Ethics
Regulated by design

Ethics

Use evidence, governance and transparency as design principles rather than marketing afterthoughts.

Our Commitments

  • Use explainable scoring, provenance and data freshness controls
  • Maintain strong information governance and auditability
  • Communicate clearly about what is live, piloted or future-state
  • Keep patient safety and public trust at the centre of every system
Integrated operating model

How our divisions deliver the mission

Each part of the group contributes differently to science, access and ethics, creating a more coherent medicines infrastructure model.

NEUVIOR® Labs

Innovation

Applied research, product feasibility and IP development for future therapeutic, workflow and manufacturing adjacencies.

Access

Focuses research on scalable, cost-aware opportunities that can improve real-world medicines systems.

Ethics

Grounds new ideas in evidence discipline, validation planning and regulated thinking from day one.

PHARMORIS® / NEUVIOR® OS

Innovation

A medicines value operating system for commissioners and providers, built around Discover / Justify / Deploy.

Access

Helps health systems find and implement better-value opportunities faster and with more confidence.

Ethics

Uses provenance, assurance, explainable scoring and role-based access to support scrutiny.

NEUVIOR® Rx & Pharmacy

Innovation

Connect supply, distribution and frontline operations so insight can become delivery.

Access

Improve continuity of medicines access through better route-to-market thinking, pharmacy workflows and patient-facing execution.

Ethics

Prioritise governance, counselling, accountability and safer implementation on the ground.

Together, these divisions turn the mission from philosophy into operating capability by connecting research, decision support, supply and care delivery.

Recognition & Accreditation

🏛️
NHS DSPTStandards Met (2025-26)
🛡️
ICORegistration ZA606195
🏆
Innovate UKGrowth Catalyst Award
⚖️
IPO UKTrade mark published
✔️
MHRA-alignedBuilt for regulation
⚙️
GovernanceSIRO, DPO & Caldicott
Join our mission

Partner with NEUVIOR®

We welcome NHS organisations, investors, strategic partners, journalists and governance stakeholders who want a more robust medicines system.

NHS & system partners

Explore PHARMORIS pilots, commissioning workflows, provider use cases and medicines value programmes.

Discuss a pilot

Investors

Back a UK pharmaceutical group building infrastructure across AI, supply, pharmacy, labs and protected product architecture.

Investment conversations

Media, policy & governance

Speak with our team about assurance, product strategy, supply resilience and the future of medicines infrastructure.

Press and policy enquiries

Get in touch

Whether your interest is commercial, editorial, strategic or regulatory, we welcome thoughtful conversations with people who take medicines systems seriously.

We'll respond within 24 hours

NEUVIOR®

Building pharmaceutical Infrastructure with intelligence and integrity.

Infrastructure
Intelligence
Integrity